Figure 1From: Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registryComorbidities according to HbA1c (upper panel) and BP (lower panel) target groups. Legend: HbA1c, glycated hemoglobin; SBP, systolic blood pressure; TIA, transient ischemic attack; PAD, peripheral arterial disease; NPDR, non-proliferative diabetic retinopathy.Back to article page